Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.00
-$0.005-0.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.43M | -13.28M | -13.48M | -12.51M | -12.45M |
| Total Depreciation and Amortization | 421.00K | 418.00K | 418.00K | 430.00K | 436.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.45M | 1.28M | 2.06M | 1.26M | 1.29M |
| Change in Net Operating Assets | -3.72M | 297.00K | 1.31M | -1.47M | -413.00K |
| Cash from Operations | -14.29M | -11.29M | -9.69M | -12.29M | -11.14M |
| Capital Expenditure | -279.00K | -263.00K | 0.00 | -89.00K | -15.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -279.00K | -263.00K | 0.00 | -89.00K | -15.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -151.00K | -211.00K | -205.00K | -204.00K | -204.00K |
| Issuance of Common Stock | -- | 76.43M | 31.00K | 1.00K | 2.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.16M | -212.00K | -304.00K | -- |
| Cash from Financing | -151.00K | 73.06M | -386.00K | -507.00K | -202.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.72M | 61.51M | -10.08M | -12.89M | -11.36M |